International Stem Cell Corporation
International Stem Cell Corporation (ISCO), headquartered in the United States, is a pioneering entity in the biotechnology industry, specialising in stem cell research and regenerative medicine. Founded in 2007, ISCO has made significant strides in developing innovative therapies and products, particularly in the fields of cell therapy and human therapeutic applications. The company is renowned for its unique human parthenogenetic stem cell technology, which offers a promising alternative to traditional stem cell sources. ISCO's core products include stem cell lines and related research tools, which are designed to advance scientific understanding and therapeutic potential. With a strong market position, ISCO has achieved notable milestones, including collaborations with leading research institutions and advancements in clinical applications, solidifying its reputation as a leader in the stem cell sector.
DitchCarbon Score
How does International Stem Cell Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
International Stem Cell Corporation's score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
International Stem Cell Corporation's reported carbon emissions
International Stem Cell Corporation, headquartered in the US, currently does not have publicly available data on its carbon emissions, as no specific emissions figures have been reported. Additionally, there are no documented reduction targets or climate pledges outlined by the company. This absence of data suggests that the corporation may still be in the early stages of formalising its climate commitments or may not have publicly disclosed its sustainability initiatives. In the context of the biotechnology industry, companies are increasingly recognising the importance of addressing climate change and are often encouraged to set measurable targets for reducing greenhouse gas emissions.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
International Stem Cell Corporation is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
